Küleon Receives Another Favorable PCT Search Report and Written Opinion from WIPO.

Within Küleon’s third patent publication the company discloses a wide array of conformationally-constrained ligands that exhibit unique selectivity for serotonin receptor subtypes.

Please click the link below to read more: